SlideShare a Scribd company logo
Connectivity
Interacting, Collaborating, and Networking
Meet Mary
Mary became a PharmaCom
Project Manager this week
after spending 6 years in
Basic Research. She will be
working with her team to
determine if their drug
candidate is viable. She has
been learning how to
navigate the rest of the PRL
community outside of the
labs and is beginning to get
the hang of things.
Because she is at a
different site, Mary remotely
learns the procedures and
operations of her job from
her manager, Melanie.
Meet Melanie
Melanie has been a
PharmaCom Project
Manager for nearly 20 years
and has contacts in every
area of PRL. She wishes she
could spend more time
mentoring new hires like
Mary, but with her busy
schedule she winds up being
more of a reference than a
coach.
Knowing how important
networking is at
PharmaCom, Melanie
encourages Mary to connect
with her colleagues and gain
a better understanding of
who they are, their role on
the project, and most
importantly, what they are
passionate about.




                               Colleagues at Lunch
Taking Melanie’s advice, Mary reads most of the documentation
from the project teamspace and does research on her teammates
using internal PharmaCom resources prior to her first meeting with
them.
She also checks out some of the papers they have
written and becomes familiar with their interests and
areas of expertise.
Although she has not personally met them, Mary feels that
she is now acquainted with her colleagues.
Even though the prep work helped Mary learn more about
her teammates on an individual level, it didn’t prepare her
for the complex dynamics of working with a team spread
out over multiple work sites.
In her first project meeting, Mary is introduced to the
team. Most of the attendees are teleconferencing in
from other sites around the world.
Because it is difficult for her to tell how everyone is
reacting to the discussion, she often finds herself
interrupting and speaking over people.
She also feels that only a small portion of the
attendees are openly contributing to the meeting.
As she feared, a few attendees
reach out afterwards to further
discuss agenda items that were
either closed or tabled for sub-
team review.
For the next meeting, Mary
decides to set up a video
conference as a way of avoiding
some of the awkwardness of the
last meeting. This way, everyone
can see each other and have a
more open conversation.
During the meeting, a question is brought up about the
quantitative PCR of a particular sodium molecule with
liver cells that no one can answer – including Thomas.
Meet Thomas
Thomas is a Senior Lab
Chemist in PRL's Basic
Research division. He's been
with PharmaCom for 20 years
and identifies with the
company values of knowledge
and peer contacts. Although
some of that time was spent
abroad in the US, he recently
returned back to his hometown
of Hoddesdon in the UK.
To avoid interrupting the discussion taking place, Mary uses
the meeting chat tool to ask Thomas if he has any ideas
around who might have the answer.
Based on Thomas’s
response, Mary makes a note
to post the team’s question to
PharmaCom’s Q&A board.
She is confident that between
this and her list of knowledge
profiles for liver cell biologists,
she will soon have an answer.
As the meeting winds down, Mary observes that things seemed to run
more smoothly. More people actively participated in the discussion and
it was easier to interpret reactions to challenging topics thanks to being
able to see facial reactions and body language.
To see what everyone else thinks, Mary does a pulse check and is
pleased to see that the new format got a thumbs up from most
attendees. She is also pleased to see that her inbox has not been
inundated with “off-line” follow-ups to decisions from the meeting.
Sub-teams post their off-line
discussions to the team wiki
and voting tools are used to
make decisions between
meetings. Most importantly, all
meetings are immediately
uploaded to the project
teamspace for those who
couldn’t make the meeting live.
Thanks to fewer email follow-
ups, Mary has time to post the
team’s question to
PharmaCom’s Q&A tool
immediately following the
meeting. She quickly starts
receiving answers back – not
only from PRL colleagues, but
from some of their research
partner colleagues as well.
She enters search keywords
such as, “liver”, “cellular
biology”, and “sodium + qPCR”
to narrow down the list of
responses and notices that a
great deal of the remaining
answers are from Andrew Cai,
a scientist from one of
PharmaCom’s research
partners.
Meet Andrew
Andrew joined the PRL team
2 years ago as a research
partner and is considered by
many to be an up and coming
thought leader in liver cell
biology. He is excited to be
working with PharmaCom
because of its dedication to
research and has already
made many connections in
the PRL community.
In Andrew's profile, Mary sees that several people have
rated him favorably for answering their questions quickly and
efficiently.
When Thomas hears about
Andrew, he is skeptical. He
has never met Andrew and
knows little about who he is
beyond the fact that Mary
found him on some
“website”.
However, going through his
own network, Thomas learns
that Andrew was a graduate
student of his old professor at
Brown. Thomas also learns
that his colleagues like
working with Andrew because
he always makes sure his
data is relevant by referencing
the PharmaCom databases
before submitting his
response.

Hearing approval from some
trusted members of his
network, Thomas feels more
comfortable with Andrew’s
response.
Now in direct contact with
one another, Thomas and
Andrew collaborate virtually
on some molecular
structures by drawing them
out to avoid naming
mishaps.
As Thomas and Andrew
finish up their
collaboration, a Safety
Assessment and Pre-
Clinical sub-team begins to
look more closely at the
drug candidate to better
understand the compound
toxicity.
With each member as an
author, the Safety
Assessment and Pre-Clinical
sub-team iterates on their
report for the committee
reviews.
At the end of the Development
Phase, Mary and the Clinical
Research Associate use the
Teamspace to coordinate the
IND application. They
reference the meeting
recordings and sub-team wikis
as project support.
Later, when the project
moves into Phase I testing,
the Data Manager, Robert,
sets up a reporting
environment for Mary.
Meet Robert
Although he is relatively
new to PharmaCom and
PRL having only joined 2
years ago, he has been in
the area of Clinical
Operations for 9 years.
His detail-oriented
personality and flexible
demeanor is an asset as
he coordinates sites
around the country and
implements clinical trials.
In the reporting
environment, site
investigators enter their
results as soon as they have
them. Mary and Robert log
into the environment to see
the data.
Mary subscribes to the environment so that she receives
batch updates of Robert's clinical reports and operational
plans.
If the project has an issue, Mary knows immediately and
can make adjustments before it becomes a problem.
Overall, the different voices of the research lifecycle came together
seamlessly with the help of different types of collaboration tools to
help foster creativity and accelerate innovation.
Decision times were condensed, information was accessed
regardless of time or location, and a team that never met in person
worked as if they had known each other for years and were seated
right next to one another.

More Related Content

Similar to Connectivity and Collaboration

1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
BenitoSumpter862
 
1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
SantosConleyha
 
Pivoting for Success - Evolving with the Healthcare Market
Pivoting for Success - Evolving with the Healthcare MarketPivoting for Success - Evolving with the Healthcare Market
Pivoting for Success - Evolving with the Healthcare Market
Jon Michaeli
 
LinkedIn Tips For The Biotech Professional
LinkedIn Tips For The Biotech ProfessionalLinkedIn Tips For The Biotech Professional
LinkedIn Tips For The Biotech Professional
LinkedIn
 
Making long-distance relation.docx
Making long-distance relation.docxMaking long-distance relation.docx
Making long-distance relation.docx
tarifarmarie
 
Critique Paper Example - How To Write Critique Pap
Critique Paper Example - How To Write Critique PapCritique Paper Example - How To Write Critique Pap
Critique Paper Example - How To Write Critique Pap
Lisa Graves
 
Revised eBook (complete layout)
Revised eBook (complete layout)Revised eBook (complete layout)
Revised eBook (complete layout)
Ridzwan Arifin
 
Role of voice in the marketplace
Role of voice in the marketplaceRole of voice in the marketplace
Role of voice in the marketplace
Cassie Murphey-Green
 
Executive communicationsurvey (2)
Executive communicationsurvey (2)Executive communicationsurvey (2)
Executive communicationsurvey (2)
972vickie
 
BADM440-1404A-01Roderick D. GoodrumClass Discussion Phase 3C.docx
BADM440-1404A-01Roderick D. GoodrumClass Discussion Phase 3C.docxBADM440-1404A-01Roderick D. GoodrumClass Discussion Phase 3C.docx
BADM440-1404A-01Roderick D. GoodrumClass Discussion Phase 3C.docx
ikirkton
 
Unit Eight Theory Rewrite
Unit Eight Theory RewriteUnit Eight Theory Rewrite
Unit Eight Theory Rewrite
Lauren Fowler-Carter
 
Finnish Red Cross Project
Finnish Red Cross ProjectFinnish Red Cross Project
Finnish Red Cross Project
Saad Jamil
 
Responses to Other Students Respond to at least 2 of your fellow .docx
Responses to Other Students Respond to at least 2 of your fellow .docxResponses to Other Students Respond to at least 2 of your fellow .docx
Responses to Other Students Respond to at least 2 of your fellow .docx
ronak56
 
Cap Today Lean Article 10 2008
Cap Today Lean Article 10 2008Cap Today Lean Article 10 2008
Cap Today Lean Article 10 2008
hfroehling1
 
Learning by Doing and Applying our Learning
Learning by Doing and Applying our LearningLearning by Doing and Applying our Learning
Learning by Doing and Applying our Learning
IDS
 
A Pharmacist From Philadelphia Is A Great Choice
A Pharmacist From Philadelphia Is A Great Choice  A Pharmacist From Philadelphia Is A Great Choice
A Pharmacist From Philadelphia Is A Great Choice
Ray Mirra
 
FDA Social Media Review From Dose Of Digital
FDA Social Media Review From Dose Of DigitalFDA Social Media Review From Dose Of Digital
FDA Social Media Review From Dose Of Digital
Jonathan Richman
 
SMi MasterClass: Social Media in Pharmaceuticals 14 April 2010
SMi MasterClass: Social Media in Pharmaceuticals 14 April 2010SMi MasterClass: Social Media in Pharmaceuticals 14 April 2010
SMi MasterClass: Social Media in Pharmaceuticals 14 April 2010
CREATION
 
Social Media in Pharmaceuticals Masterclass14 04
Social Media in Pharmaceuticals Masterclass14 04Social Media in Pharmaceuticals Masterclass14 04
Social Media in Pharmaceuticals Masterclass14 04
Warren Hamilton
 
Wave 2: Learning Session 1
Wave 2: Learning Session 1Wave 2: Learning Session 1
Wave 2: Learning Session 1
marc van der woerd
 

Similar to Connectivity and Collaboration (20)

1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
 
1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
1.Jaquayle Deonte Robinson835pmApr 16 at 835pmManage Discu
 
Pivoting for Success - Evolving with the Healthcare Market
Pivoting for Success - Evolving with the Healthcare MarketPivoting for Success - Evolving with the Healthcare Market
Pivoting for Success - Evolving with the Healthcare Market
 
LinkedIn Tips For The Biotech Professional
LinkedIn Tips For The Biotech ProfessionalLinkedIn Tips For The Biotech Professional
LinkedIn Tips For The Biotech Professional
 
Making long-distance relation.docx
Making long-distance relation.docxMaking long-distance relation.docx
Making long-distance relation.docx
 
Critique Paper Example - How To Write Critique Pap
Critique Paper Example - How To Write Critique PapCritique Paper Example - How To Write Critique Pap
Critique Paper Example - How To Write Critique Pap
 
Revised eBook (complete layout)
Revised eBook (complete layout)Revised eBook (complete layout)
Revised eBook (complete layout)
 
Role of voice in the marketplace
Role of voice in the marketplaceRole of voice in the marketplace
Role of voice in the marketplace
 
Executive communicationsurvey (2)
Executive communicationsurvey (2)Executive communicationsurvey (2)
Executive communicationsurvey (2)
 
BADM440-1404A-01Roderick D. GoodrumClass Discussion Phase 3C.docx
BADM440-1404A-01Roderick D. GoodrumClass Discussion Phase 3C.docxBADM440-1404A-01Roderick D. GoodrumClass Discussion Phase 3C.docx
BADM440-1404A-01Roderick D. GoodrumClass Discussion Phase 3C.docx
 
Unit Eight Theory Rewrite
Unit Eight Theory RewriteUnit Eight Theory Rewrite
Unit Eight Theory Rewrite
 
Finnish Red Cross Project
Finnish Red Cross ProjectFinnish Red Cross Project
Finnish Red Cross Project
 
Responses to Other Students Respond to at least 2 of your fellow .docx
Responses to Other Students Respond to at least 2 of your fellow .docxResponses to Other Students Respond to at least 2 of your fellow .docx
Responses to Other Students Respond to at least 2 of your fellow .docx
 
Cap Today Lean Article 10 2008
Cap Today Lean Article 10 2008Cap Today Lean Article 10 2008
Cap Today Lean Article 10 2008
 
Learning by Doing and Applying our Learning
Learning by Doing and Applying our LearningLearning by Doing and Applying our Learning
Learning by Doing and Applying our Learning
 
A Pharmacist From Philadelphia Is A Great Choice
A Pharmacist From Philadelphia Is A Great Choice  A Pharmacist From Philadelphia Is A Great Choice
A Pharmacist From Philadelphia Is A Great Choice
 
FDA Social Media Review From Dose Of Digital
FDA Social Media Review From Dose Of DigitalFDA Social Media Review From Dose Of Digital
FDA Social Media Review From Dose Of Digital
 
SMi MasterClass: Social Media in Pharmaceuticals 14 April 2010
SMi MasterClass: Social Media in Pharmaceuticals 14 April 2010SMi MasterClass: Social Media in Pharmaceuticals 14 April 2010
SMi MasterClass: Social Media in Pharmaceuticals 14 April 2010
 
Social Media in Pharmaceuticals Masterclass14 04
Social Media in Pharmaceuticals Masterclass14 04Social Media in Pharmaceuticals Masterclass14 04
Social Media in Pharmaceuticals Masterclass14 04
 
Wave 2: Learning Session 1
Wave 2: Learning Session 1Wave 2: Learning Session 1
Wave 2: Learning Session 1
 

Connectivity and Collaboration

  • 2. Meet Mary Mary became a PharmaCom Project Manager this week after spending 6 years in Basic Research. She will be working with her team to determine if their drug candidate is viable. She has been learning how to navigate the rest of the PRL community outside of the labs and is beginning to get the hang of things.
  • 3. Because she is at a different site, Mary remotely learns the procedures and operations of her job from her manager, Melanie.
  • 4. Meet Melanie Melanie has been a PharmaCom Project Manager for nearly 20 years and has contacts in every area of PRL. She wishes she could spend more time mentoring new hires like Mary, but with her busy schedule she winds up being more of a reference than a coach.
  • 5. Knowing how important networking is at PharmaCom, Melanie encourages Mary to connect with her colleagues and gain a better understanding of who they are, their role on the project, and most importantly, what they are passionate about. Colleagues at Lunch
  • 6. Taking Melanie’s advice, Mary reads most of the documentation from the project teamspace and does research on her teammates using internal PharmaCom resources prior to her first meeting with them.
  • 7. She also checks out some of the papers they have written and becomes familiar with their interests and areas of expertise.
  • 8. Although she has not personally met them, Mary feels that she is now acquainted with her colleagues.
  • 9. Even though the prep work helped Mary learn more about her teammates on an individual level, it didn’t prepare her for the complex dynamics of working with a team spread out over multiple work sites.
  • 10. In her first project meeting, Mary is introduced to the team. Most of the attendees are teleconferencing in from other sites around the world.
  • 11. Because it is difficult for her to tell how everyone is reacting to the discussion, she often finds herself interrupting and speaking over people.
  • 12. She also feels that only a small portion of the attendees are openly contributing to the meeting.
  • 13. As she feared, a few attendees reach out afterwards to further discuss agenda items that were either closed or tabled for sub- team review.
  • 14. For the next meeting, Mary decides to set up a video conference as a way of avoiding some of the awkwardness of the last meeting. This way, everyone can see each other and have a more open conversation.
  • 15. During the meeting, a question is brought up about the quantitative PCR of a particular sodium molecule with liver cells that no one can answer – including Thomas.
  • 16. Meet Thomas Thomas is a Senior Lab Chemist in PRL's Basic Research division. He's been with PharmaCom for 20 years and identifies with the company values of knowledge and peer contacts. Although some of that time was spent abroad in the US, he recently returned back to his hometown of Hoddesdon in the UK.
  • 17. To avoid interrupting the discussion taking place, Mary uses the meeting chat tool to ask Thomas if he has any ideas around who might have the answer.
  • 18. Based on Thomas’s response, Mary makes a note to post the team’s question to PharmaCom’s Q&A board. She is confident that between this and her list of knowledge profiles for liver cell biologists, she will soon have an answer.
  • 19. As the meeting winds down, Mary observes that things seemed to run more smoothly. More people actively participated in the discussion and it was easier to interpret reactions to challenging topics thanks to being able to see facial reactions and body language.
  • 20. To see what everyone else thinks, Mary does a pulse check and is pleased to see that the new format got a thumbs up from most attendees. She is also pleased to see that her inbox has not been inundated with “off-line” follow-ups to decisions from the meeting.
  • 21. Sub-teams post their off-line discussions to the team wiki and voting tools are used to make decisions between meetings. Most importantly, all meetings are immediately uploaded to the project teamspace for those who couldn’t make the meeting live.
  • 22. Thanks to fewer email follow- ups, Mary has time to post the team’s question to PharmaCom’s Q&A tool immediately following the meeting. She quickly starts receiving answers back – not only from PRL colleagues, but from some of their research partner colleagues as well.
  • 23. She enters search keywords such as, “liver”, “cellular biology”, and “sodium + qPCR” to narrow down the list of responses and notices that a great deal of the remaining answers are from Andrew Cai, a scientist from one of PharmaCom’s research partners.
  • 24. Meet Andrew Andrew joined the PRL team 2 years ago as a research partner and is considered by many to be an up and coming thought leader in liver cell biology. He is excited to be working with PharmaCom because of its dedication to research and has already made many connections in the PRL community.
  • 25. In Andrew's profile, Mary sees that several people have rated him favorably for answering their questions quickly and efficiently.
  • 26. When Thomas hears about Andrew, he is skeptical. He has never met Andrew and knows little about who he is beyond the fact that Mary found him on some “website”.
  • 27. However, going through his own network, Thomas learns that Andrew was a graduate student of his old professor at Brown. Thomas also learns that his colleagues like working with Andrew because he always makes sure his data is relevant by referencing the PharmaCom databases before submitting his response. Hearing approval from some trusted members of his network, Thomas feels more comfortable with Andrew’s response.
  • 28. Now in direct contact with one another, Thomas and Andrew collaborate virtually on some molecular structures by drawing them out to avoid naming mishaps.
  • 29. As Thomas and Andrew finish up their collaboration, a Safety Assessment and Pre- Clinical sub-team begins to look more closely at the drug candidate to better understand the compound toxicity.
  • 30. With each member as an author, the Safety Assessment and Pre-Clinical sub-team iterates on their report for the committee reviews.
  • 31. At the end of the Development Phase, Mary and the Clinical Research Associate use the Teamspace to coordinate the IND application. They reference the meeting recordings and sub-team wikis as project support.
  • 32. Later, when the project moves into Phase I testing, the Data Manager, Robert, sets up a reporting environment for Mary.
  • 33. Meet Robert Although he is relatively new to PharmaCom and PRL having only joined 2 years ago, he has been in the area of Clinical Operations for 9 years. His detail-oriented personality and flexible demeanor is an asset as he coordinates sites around the country and implements clinical trials.
  • 34. In the reporting environment, site investigators enter their results as soon as they have them. Mary and Robert log into the environment to see the data.
  • 35. Mary subscribes to the environment so that she receives batch updates of Robert's clinical reports and operational plans.
  • 36. If the project has an issue, Mary knows immediately and can make adjustments before it becomes a problem.
  • 37. Overall, the different voices of the research lifecycle came together seamlessly with the help of different types of collaboration tools to help foster creativity and accelerate innovation.
  • 38. Decision times were condensed, information was accessed regardless of time or location, and a team that never met in person worked as if they had known each other for years and were seated right next to one another.